Phase
Condition
Skin Wounds
Hyponatremia
Treatment
FibDex
Epiprotect
Epicite hydro
Clinical Study ID
Ages > 1 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Signed written informed consent (by the patient and/or the patient's parent[s]/legalguardian[s] as applicable).
Patient with superficial dermal burn wound(s) (class II/A) ≤36h as assessed by theInvestigator.
Patient at least 1 year old.
Patient who has at least 3 superficial dermal burn wounds on anatomically equivalentareas or a superficial dermal burn large enough to allow a lateral comparison.
Wound area at least 50 cm2 (per wound, if 3 separate wounds) or at least 150 cm2 (ifsingle wound) as judged by the Investigator.
Exclusion
Exclusion Criteria:
Patient hyper-sensitive or allergic to, or have had a hypersensitivity/allergicreaction to, any of the dressing components.
Pregnant or breast-feeding female.
Patient with chemically or electrically induced burns.
Other non-burn wound in target wound area.
Not suitable for inclusion according to the Investigator.
Cognitive dysfunction or psychiatric history (Investigator's discretion).
Chronic or presently active skin condition that is judged as interfering with normalwound healing process (Investigator's discretion)
Target burns on sensitive skin areas, such as the facial or genital area.
Inability or unwillingness of participant or parent(s)/legal guardian(s) to givewritten informed consent.
Study Design
Connect with a study center
Burn Centre, Uppsala University Hospital
Uppsala,
SwedenSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.